TMC
DSCI

Trellus Management Company’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Trellus Management Company’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,000
Closed -$70K – 92
2016
Q3 		$70K Buy
+15,000
New +$70K 0.1% 65

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Trellus Management Company's DSCI Position: Q4 2016 in Review

Trellus Management Company sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 15,000 shares — an estimated $70K sold.

Trellus Management Company first reported a position in DSCI in Q3 2016 and held it in 1 quarter. The position peaked at $70K in Q3 2016. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

  • Trellus Management Company reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
  • Trellus Management Company sold 15,000 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $70K.
  • Trellus Management Company first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2016 and held it in 1 quarter.
  • Trellus Management Company's Derma Sciences, Inc. Common Stock (DE) position peaked at $70K in Q3 2016.
  • 52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on Trellus Management Company's 13F filing for Q4 2016, filed 31 Jan 2017.